DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Fasching PA, Loibl S, Hu C. et al.
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.

J Clin Oncol 2018;
DOI: 10.1200/JCO.2017.77.2285.

Download Bibliographical Data

Search in: